Multisystem Inflammatory Syndrome in Children: An International Survey

Carles Bautista-Rodriguez1,2,3, Joan Sanchez-de-Toledo4,5,3, Bradley C Clark6,7

  • 1Paediatric Cardiology Services, Royal Brompton Hospital, London, United Kingdom.

Pediatrics
|November 25, 2020
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) presents with varied symptoms, from Kawasaki disease-like illness to shock. Shorter symptom duration before hospital admission is linked to worse outcomes in pediatric MIS-C patients.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Rheumatology

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious condition following SARS-CoV-2 infection.
  • Understanding MIS-C's clinical spectrum and outcomes is crucial for timely intervention.

Purpose of the Study:

  • To delineate the clinical presentation, hospital course, and predictors of adverse outcomes in children diagnosed with MIS-C.
  • Identify factors associated with severe disease and poor prognosis in pediatric MIS-C.

Main Methods:

  • Retrospective analysis of a case series involving 183 children diagnosed with MIS-C across 33 international hospitals.
  • Data collection included clinical, laboratory, and imaging findings, as well as treatment management, via a web-based survey.

Main Results:

  • The study included 183 MIS-C patients (mean age 7.0 years; 59.6% male; 30.6% Black).
  • 62.3% had evidence of SARS-CoV-2 infection. Common presentations included fever (100%), gastrointestinal symptoms (63.9%), and shock (43.2%).
  • A shorter duration of symptoms before admission was significantly associated with increased risk of poor outcomes, including extracorporeal membrane oxygenation or death (OR 0.723, P = .006).

Conclusions:

  • MIS-C exhibits a broad clinical spectrum in children, ranging from Kawasaki disease-like presentations to severe shock and milder inflammatory forms.
  • Early presentation with fewer symptoms before hospitalization is a critical predictor of worse outcomes in pediatric MIS-C.
Abstract